Home3NK • FRA
add
Alphamab Oncology
Previous close
€0.96
Day range
€0.97 - €0.97
Year range
€0.65 - €1.68
Market cap
8.76B HKD
Avg Volume
31.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 123.40M | -47.10% |
Operating expense | 184.22M | 47.62% |
Net income | -67.76M | -164.15% |
Net profit margin | -54.91 | -221.27% |
Earnings per share | — | — |
EBITDA | -60.88M | -155.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.35B | -14.07% |
Total assets | 2.10B | -6.45% |
Total liabilities | 386.17M | -5.78% |
Total equity | 1.71B | — |
Shares outstanding | 968.57M | — |
Price to book | 0.54 | — |
Return on assets | -9.18% | — |
Return on capital | -10.49% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -67.76M | -164.15% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2008
Website
Employees
498
